Healthcare - Biotechnology - NASDAQ - US
$ 0.22
0 %
$ 940 K
Market Cap
-0.08
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
161.61%
EBIT
Estimate
--35.38%
Net Income
Estimate
34.94%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Histogen Inc.
HSTO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart HSTO
EBIT FORECAST
EBIT Forecast Chart HSTO
NET INCOME FORECAST
Net Income Chart HSTO